Biotech foods: a closed and reopened case

Article Abstract:

No evidence that foods from biotech crops on the market are unsafe exists according to representatives of Dow AgroSciences LLC, who advocate greater understanding of risk assessment and detail the analytical-deliberative process used in their company. Pros and cons on biotechnology foods, those that are genetically modified or created using genetic engineering, continue to be of interest from points of view in science and politics and from the emotional standpoint in the public. The foods are produced by modern recombinant DNA technology and were first commercially introduced in the US in 1995. They offer financial and management advantages to farmers and have been increasingly popular with them, about 70 mil acres being planted in 1999. Topics include implementation of the holistic approach to understanding risk, new approaches to risk analysis, and data behind the products. Misconceptions and concerns are listed with counterarguments. US regulations are listed.

Risk assessment, Product information, Quality management, Agricultural chemicals industry, Genetically modified plants, Recombinant DNA, United States. Department of Agriculture, Seeds, United States. Food and Drug Administration, Biotechnology, Plant genetic engineering, Food law, Seed industry, Dow Agrosciences LLC

---

The promise and pitfalls of human testing

Article Abstract:

Use of human subjects in testing may make pesticides safer or may add to profits for industry. The Environmental Protection Agency (EPA) is considering recommendations as it designs its final policy on human testing and convened a joint panel of the Scientific Advisory Board and scientific Advisory Panel in late 1998. The panel is to prepare a set of recommendations on the proper role of human studies in regulatory decision making, risks and benefits of human testing for subjects and society, and appropriate ethical standards for human experiments. It is to consider Common Rule and the Declaration of Helsinki by the World Medical Association. Apparently difficulty in getting panel members to agree on the issues exists. Patients given a neurotoxic insecticide orally in the United Kingdom by Medeval Laboratories on behalf of the Amvac Chemical (California) are discussed as are tests using laboratory animals.

Research, Testing, Ethical aspects, Chemical industry, Product development, Environmental sciences, Laboratory animals, Pesticides industry, Pesticides, Bioethics

---

Of PCBs and the river

Article Abstract:

This article discusses the cleanup operations to be undertaken by General Electric Company for dredging the Hudson River to remove polychlorinated biphenyls (PCBs). Implications of this remediation project to remove or reduce the significant environmental and aquatic animal health threat are presented.

Environmental aspects, General Electric Co., GE, Polychlorinated biphenyls, Hudson River, Dredging

Similar abstracts:

• Abstracts: A Quality Library for a Desert Island. Get around the box. Resumes: before and after: three HR experts offer tips
• Abstracts: South Korea pushes mobile broadband. Seven myths about Voice over IP. A broadband utopia
• Abstracts: Site visits illustrate advanced grid design. I've got the power
• Abstracts: Dynamic control of a cellular-line production system under variations in the product mix. An empirical analysis of productivity and complexity for flexible manufacturing systems
• Abstracts: Manage IP costs with technical disclosures. Eye of newt and toe of frog

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.